During the past decade, Hopital de Montbeliard conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital de Montbeliard" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hopital de Montbeliard" are "Metastatic Colorectal Cancer" (2 trials), "Anal Canal Carcinoma" (1 trials), "Breast Cancer" (1 trials), "Lower Oesophagus Cancer" (1 trials) and "Metastases" (1 trials). Many other conditions were trialed in "Hopital de Montbeliard" in a lesser frequency.

Most popular intervention types in "Hopital de Montbeliard" are "Drug" (6 trials), "Radiation" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab control" (1 trials), "Bevacizumab experimental" (1 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials) and "Docetaxel, Cisplatin and 5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital de Montbeliard" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital de Montbeliard". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hopital de Montbeliard, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital de Montbeliard, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".